Return to homepagePandemic Pact

Development of Medical Countermeasures for COVID-19

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201300017C-P00026-9999-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $440,828

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    RAYMOND TAYLOR

  • Research Location

    United States of America

  • Lead Research Institution

    BIOCRYST PHARMACEUTICALS, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This contract supports the advanced development of promising therapeutic candidates with broad spectrum activity. The research and development activities to be supported will allow candidate therapeutic products to progress through the product development pipeline, and includes preclinical and non-clinical activities, as well as IND development activities.